Home > Insider Trading > Filing (0001209191-13-048970)

Filing Details

Accession Number:: 0001209191-13-048970
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-22 19:11:40
Reporting Period:: 2013-10-21

Filing Date:: 2013-10-22
Accepted Time:: 2013-10-22 19:11:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131096	Athenahealth Inc	ATHN	Services-Business Services, Nec (7389)	043387530

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1298669	M Timothy Adams	311 Arsenal Street Watertown MA 02472	Cfo & Svp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-10-21	20,000	$40.90	64,019	No	4	M	Direct
Common Stock	Disposition	2013-10-21	2,000	$133.94	62,019	No	4	S	Direct
Common Stock	Disposition	2013-10-21	1,000	$135.56	61,019	No	4	S	Direct
Common Stock	Disposition	2013-10-21	2,000	$136.40	59,019	No	4	S	Direct
Common Stock	Disposition	2013-10-21	1,100	$137.44	57,919	No	4	S	Direct
Common Stock	Disposition	2013-10-21	3,100	$138.30	54,819	No	4	S	Direct
Common Stock	Disposition	2013-10-21	7,300	$139.73	47,519	No	4	S	Direct
Common Stock	Disposition	2013-10-21	3,500	$140.45	44,019	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-10-21	20,000	$0.00	20,000	$40.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
70,000	2011-01-11	2020-02-01	No	4	M	Direct

Footnotes

Includes 115 shares purchased pursuant to the Issuer's 2007 Employee Stock Purchase Plan on September 30, 2013, which transaction is considered exempt pursuant to Rule 16b-3(c) promulgated under the Securities Exchange Act of 1934.
The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on August 20, 2013, in accordance with Rule 10b5-1.
This price represents the weighted average of sales ranging from $135.43 to $135.90. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average of sales ranging from $136.00 to $136.91. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average of sales ranging from $137.00 to $137.99. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average of sales ranging from $138.00 to $138.99. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average of sales ranging from $139.50 to $140.00. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average of sales ranging from $140.03 to $141.02. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.